Head-to-Head

Akari Therapeutics plc ADR (0.01 USD) vs. Johnson & Johnson

AKTX

Akari Therapeutics plc ADR (0.01 USD)

$6.51 -12.62%

VS JNJ

Johnson & Johnson

$283.52 +1.11%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AKTXJNJ
Market Cap $14.88 million $675.03 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

AKTXJNJ
Dividend Yield — 1.89%

AKTX and JNJ split the dividend factors evenly.

Risk & Sentiment

AKTXJNJ
Short Interest 25.74% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: AKTX overview, AKTX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.